Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Technology Holdings is a global boutique investment banking and advisory firm that historically operated under the name Technology Holdings and has since rebranded to TH Global Capital. The firm provides sell-side and buy-side M&A, growth capital, debt advisory, IPO advisory, asset management, and growth advisory services across several sectors, including Healthcare & Life Sciences. Its healthcare activity is advisory-focused rather than therapeutic or product-driven, with transactions involving life sciences commercialization, medtech, and healthcare services businesses. The company is therefore relevant to healthcare dealmaking but is not itself a biotech, pharma, medtech developer, CRO, or CDMO. A biotech analyst should view it primarily as a sector-focused financial advisor serving healthcare and life sciences clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Technology Holdings.